EOS Expanding to Support U.S. Growth

EOS imaging, specialists in 2D/3D orthopedic imaging, is building out its U.S. operations by expanding commercially and organizationally. With EOS, surgeons can capture 2D and 3D full-body, stereo-radiographic images of patients in functional positions. And with these images, patients are getting a dose of radiation that is 50% to 85% less than Digital Radiology and 95% less than basic CT scans.

According to the December 9, 2015 news release, “EOS imaging’s technical support team, reinforced and led by a newly appointed manager, will focus on supporting the existing 47 EOS systems in the U.S. market, as well as the upcoming and new installations in 2016. The 6 last installations increase the U.S. installed base to 47, with 7 additional platforms shipped and pending installation.”

“Centers that focus exclusively on pediatrics make up 60% of the current U.S. installed base and include 9 of the top 10 pediatric hospitals. The remaining 40% are in hospitals focusing on the adult population including 4 of the top 10 hospitals for adult orthopedics. EOS systems are installed in hospitals of all sizes including those with 300 beds or less, which currently represent 35% of the EOS installations. There is also momentum to acquire additional systems, as was the case at 6 U.S. hospitals already, to broaden EOS® usage and turn it into internal orthopedic imaging standards across all departments and sites.”

Marie Meynadier, CEO of EOS imaging said, “The record number of installations was made possible thanks to the organizational investments we have made to support the strong momentum in the United States. The extreme reduction of irradiation with the EOS Micro Dose option is becoming a must-have in pediatric orthopedic imaging. The dose reduction and the launch of EOSapps for examination and surgical planning also reinforce EOS as a standard of care for adult orthopedic imaging. We look forward to rapidly growing our customer base and increasing the sites with multiple systems as the value of our solution is recognized.”

Eric Maulavé, Global Sales Vice President, told OTW, “This record installation in the U.S. in the last month represents an important time for our product and our company. With the EOS system now being available in 47 U.S. locations, more patients than ever can benefit from our low-dose 2D/3D scans. Additionally, we are happy that this expansion has led us to welcome new members of the team to ensure the best service after the device has been installed.”